Jpmorgan Chase & CO Black Diamond Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 17,574 shares of BDTX stock, worth $38,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,574
Previous 15,917 10.41%
Holding current value
$38,311
Previous $74,000 2.7%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$4.2 - $6.58 $6,959 - $10,903
1,657 Added 10.41%
17,574 $76,000
Q3 2024

Nov 08, 2024
BUY
$4.2 - $6.58 $6,959 - $10,903
1,657 Added 10.41%
17,574 $76,000
Q2 2024

Dec 26, 2024
SELL
$4.65 - $7.39 $7,705 - $12,245
-1,657 Reduced 9.43%
15,917 $74,000
Q2 2024

Aug 12, 2024
BUY
$4.65 - $7.39 $29,890 - $47,502
6,428 Added 67.74%
15,917 $74,000
Q1 2024

Dec 26, 2024
SELL
$2.67 - $5.74 $21,586 - $46,407
-8,085 Reduced 46.01%
9,489 $48,000
Q1 2024

May 10, 2024
SELL
$2.67 - $5.74 $2.17 Million - $4.66 Million
-812,145 Reduced 98.85%
9,489 $48,000
Q4 2023

Dec 26, 2024
BUY
$1.77 - $3.03 $1.42 Million - $2.44 Million
804,060 Added 4575.28%
821,634 $2.31 Million
Q4 2023

Feb 12, 2024
SELL
$1.77 - $3.03 $506,129 - $866,425
-285,949 Reduced 25.82%
821,634 $2.31 Million
Q3 2023

Nov 14, 2023
BUY
$2.87 - $4.99 $78,993 - $137,344
27,524 Added 2.55%
1,107,583 $3.18 Million
Q2 2023

Aug 11, 2023
BUY
$1.43 - $6.18 $1.54 Million - $6.67 Million
1,079,507 Added 195562.86%
1,080,059 $5.45 Million
Q4 2022

Feb 13, 2023
SELL
$1.27 - $2.51 $1,871 - $3,699
-1,474 Reduced 72.75%
552 $1,000
Q3 2022

Nov 14, 2022
BUY
$1.68 - $4.01 $863 - $2,061
514 Added 33.99%
2,026 $3,000
Q2 2022

Aug 11, 2022
SELL
$1.5 - $3.63 $388,440 - $940,024
-258,960 Reduced 99.42%
1,512 $4,000
Q1 2022

May 11, 2022
BUY
$2.66 - $5.61 $167,252 - $352,739
62,877 Added 31.82%
260,472 $723,000
Q4 2021

Feb 10, 2022
SELL
$5.18 - $8.48 $75,918 - $124,282
-14,656 Reduced 6.91%
197,595 $1.05 Million
Q3 2021

Nov 12, 2021
BUY
$8.46 - $12.42 $1.8 Million - $2.64 Million
212,251 New
212,251 $1.8 Million

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.2M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email